SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated November 1, 2023, serves as a notification to the market in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R. The report details the company's issued share capital and voting rights as of October 31, 2023.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure and voting rights.
- Issued Share Capital: 4,312,101,988 Ordinary Shares of 31 1/4 pence each.
- Treasury Shares: 217,068,169 Ordinary Shares held in Treasury.
- Total Voting Rights: 4,095,033,819.
Material Changes
The filing text does not provide comparative data against prior periods to identify material changes in share capital or voting rights.
Guidance, Outlook, and Risks
This document contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. Its sole purpose is to establish the denominator for shareholder notification calculations under FCA rules.
Key Facts for Investor Verification
- Verify the total voting rights count of 4,095,033,819 for compliance with FCA disclosure thresholds.
- Confirm the number of treasury shares (217,068,169) when calculating outstanding shares.
- Note that this filing does not contain operational or financial performance updates.